We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$60.8B
AUM Growth
+$1.76B
(+3%)
Cap. Flow
+$3.65B
Cap. Flow
% of AUM
6.01%
Top 10 Holdings %
Top 10 Hldgs %
23.06%
Holding
2,127
New
257
Increased
784
Reduced
545
Closed
271
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$353M |
| 2 |
AstraZeneca
AZN
|
+$299M |
| 3 |
RB Global
RBA
|
+$232M |
| 4 |
Apple
AAPL
|
+$225M |
| 5 |
American Tower
AMT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$159M |
| 2 |
Goldman Sachs
GS
|
+$156M |
| 3 |
ASE Group
ASX
|
+$136M |
| 4 |
Merck
MRK
|
+$133M |
| 5 |
Baxter International
BAX
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.82% |
| 2 | Industrials | 13.22% |
| 3 | Financials | 11.81% |
| 4 | Healthcare | 9.89% |
| 5 | Consumer Discretionary | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Thor Industries
THO
$3.99B
| $14.8M | 0.02% |
184,831
+15,628
| +9% | +$1.59M |
|
377
Primoris Services
PRIM
$4.69B
| $14.7M | 0.02% |
102,639
-91,992
| -47% | -$13.5M |
|
378
Dr. Reddy's Laboratories
RDY
$9.82B
| $14.7M | 0.02% |
1,059,831
-108,731
| -9% | -$1.51M |
|
379
RingCentral
RNG
$4.05B
| $14.4M | 0.02% |
388,157
-141,472
| -27% | -$4.56M |
|
380
First American
FAF
$7.67B
| $14.3M | 0.02% |
237,313
-195,611
| -45% | -$12.5M |
|
381
UBS Group
UBS
$170B
| $14.2M | 0.02% |
370,444
+75,251
| +25% | +$3.22M |
|
382
Wabtec
WAB
$51.1B
| $14.2M | 0.02% |
+56,622
| New | +$13.7M |
|
|
PEO
383
Adams Natural Resources Fund
PEO
$759M
| $14.1M | 0.02% |
507,006
-1,960
| -0.4% | -$49.6K |
|
384
Sprouts Farmers Market
SFM
$7.04B
| $13.9M | 0.02% |
179,691
+149,640
| +498% | +$11.2M |
|
385
Starbucks
SBUX
$118B
| $13.7M | 0.02% |
153,273
-891,740
| -85% | -$84.4M |
|
386
iShares Core US Aggregate Bond ETF
AGG
$138B
| $13.7M | 0.02% |
138,013
-36,047
| -21% | -$3.61M |
|
387
Diageo
DEO
$46.2B
| $13.6M | 0.02% |
182,390
+6,165
| +3% | +$538K |
|
388
Alexandria Real Estate Equities
ARE
$8.88B
| $13.5M | 0.02% |
+291,687
| New | +$15.4M |
|
389
Sea Limited
SE
$61.2B
| $13.5M | 0.02% |
163,381
-108,365
| -40% | -$11.6M |
|
390
Regeneron Pharmaceuticals
REGN
$68.8B
| $13.1M | 0.02% |
17,004
+6,166
| +57% | +$4.72M |
|
391
Ovintiv
OVV
$17.5B
| $13.1M | 0.02% |
220,932
+20,969
| +10% | +$1.01M |
|
392
Vanguard FTSE Europe ETF
VGK
$30B
| $12.6M | 0.02% |
153,344
-15,836
| -9% | -$1.36M |
|
393
Kimberly-Clark
KMB
$36.4B
| $12.6M | 0.02% |
130,407
-108,761
| -45% | -$11.1M |
|
|
IIF
394
Morgan Stanley India Investment Fund
IIF
$210M
| $12.5M | 0.02% |
609,359
-163,295
| -21% | -$3.81M |
|
395
Medpace
MEDP
$16.8B
| $12.3M | 0.02% |
25,640
+5,602
| +28% | +$2.87M |
|
396
Vesta Real Estate
VTMX
$3.12B
| $12.1M | 0.02% |
362,154
+61,626
| +21% | +$2.02M |
|
397
Brunswick
BC
$5.19B
| $12.1M | 0.02% |
165,660
-178,634
| -52% | -$14.4M |
|
398
Omega Healthcare
OHI
$15.4B
| $11.8M | 0.02% |
269,991
-90,494
| -25% | -$4.13M |
|
399
Sysco
SYY
$39.7B
| $11.7M | 0.02% |
163,453
+77,594
| +90% | +$6.41M |
|
400
iShares MBS ETF
MBB
$39B
| $11.5M | 0.02% |
121,088
+2,377
| +2% | +$227K |
|
Similar funds
QCM
Lazard Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Lazard Asset Management held 2,127 positions worth $60.8B, up 3% from $59B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management deployed $3.65B of net new capital in Q1 2026, opening 257 new positions and adding to 784 existing holdings. Its largest new stake was RB Global: 2,191,875 shares worth $210M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $159M trimmed.
- Lazard Asset Management's largest Q1 2026 buy was RB Global: 2,191,875 shares worth $210M.
- Lazard Asset Management added most to NVIDIA in Q1 2026, an estimated $353M increase.
- Lazard Asset Management's biggest Q1 2026 reduction was Micron Technology, cutting an estimated $159M.
- Lazard Asset Management fully exited Baxter International in Q1 2026, selling an estimated $118M.
- Lazard Asset Management's ten largest holdings make up 23% of its $60.8B portfolio in Q1 2026.
- Lazard Asset Management opened 257 new positions and closed 271 in Q1 2026.
- Lazard Asset Management's portfolio value rose 3% quarter-over-quarter to $60.8B.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.